A case in point: it turns out that only about half of the new prescription medications pushed onto the market over the last decade had the proper data together for the U.S. Food and Drug Administration - yet the FDA approved them anyhow.
The researchers found that only about half of 197 eligible approved NMEs between 2000 and 2010 had comparative efficacy data available at the time they were approved to be marketed.
Meanwhile, another recent study throws needed light on the limited data behind the safety and effectiveness of some Big Pharma drugs.
In March in a McDonald's parking lot off a busy Baltimore street, mental health clinician Michala...
Within months of being soaked with a glyphosate herbicide while working on a cell tower maintenance...
Diary entries released by a Republican senator in an attempt to damage Anthony Fauci also show...
